The role of cardiac testing with the 0/1-hour high-sensitivity cardiac troponin algorithm evaluating for acute myocardial infarction - 18/02/21
, Aeman Hana, MD b, Bernard Cook, PhD c, Michael P Hudson, MD a, Joseph Miller, MD d, Gray Akoegbe, MD e, 1, Christian Mueller, MD f, Michele Moyer, BS d, Gordon Jacobsen, PhD e, 1, Richard Nowak, MD dRiassunto |
Background |
The role of cardiac testing in the 3 zones (rule-out, observation, and rule-in) of the 0/1-hour algorithm to evaluate for acute myocardial infarction (AMI) has not been well studied. This study evaluated the 0/1-hour algorithm with a high-sensitivity cardiac troponin (hs-cTnI) assay and investigated cardiac testing in the 3 zones.
Methods |
Patients (n = 552) at a single urban center were enrolled if they were evaluated for AMI. Blood samples were obtained at presentation, 1 hour, and 3 hours for hs-cTnI. Follow-up at 30 to 45 days for death/AMI was done. The results of echocardiograms, stress testing, and coronary angiography were recorded.
Results |
In total, 45 (8.2%) had AMI (27 Type 1 and 18 Type 2) during the index hospitalization while at follow-up death/AMI occurred in 11 (2.0%) of patients. The rule-out algorithm had a negative predictive value for AMI of 99.6% while the rule-in zone had a positive predictive value of 56.6%. The MACE rate at follow-up was 0.4% for those in the rule-out group. There were 6/95 (6.3%) abnormal stress tests in the rule-out zone and 4 of these were false positives.
Conclusions |
The 0/1-hour algorithm had high diagnostic sensitivity and negative predictive value for AMI, and adverse events were very low in patients in the rule-out zone. Noninvasive testing in rule-out zone patients had low diagnostic yield.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 233
P. 68-77 - Marzo 2021 Ritorno al numero
Articolo precedente
- Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients ?65 years old: An ACC PVI Registry Analysis
- Elizabeth Hope Weissler, Amarnath Annapureddy, Yongfei Wang, Eric A. Secemsky, Mehdi H. Shishehbor, Carlos Mena-Hurtado, Qurat-Ul-Ain Jelani, Herbert D. Aronow, Thomas T. Tsai, Manesh R. Patel, Jeptha P. Curtis, William Schuyler Jones
- NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial
- Enrico Fabris, Jurrien M. ten Berg, Renicus S. Hermanides, Jan Paul Ottervanger, Jan Henk E Dambrink, AT Marcel Gosselink, Gianfranco Sinagra, Petra C. Koopmans, Evangelos Giannitsis, Christian Hamm, Arnoud W.J. van ’t Hof
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?